StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for DH yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-14 | $0.90 | $0.86 | -4.44% | 0.4M |
| 05-15 | $0.85 | $0.81 | -5.06% | 0.3M |
| 05-18 | $0.81 | $0.84 | +3.78% | 0.3M |
| 05-19 | $0.84 | $0.87 | +3.63% | 0.2M |
| 05-20 | $0.89 | $0.86 | -3.45% | 0.2M |
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $55.93M | $241.52M | $179.99M | $119.94M |
Operating Income | $-201.29M | $-224.27M | $-197.64M | $-188.96M |
Net Income | $-138.62M | $-138.93M | $-129.62M | $-114.78M |
EPS (Diluted) | $-1.32 | $-1.30 | $-1.20 | $-1.05 |
Total Assets | $514.74M | $735.49M | $755.53M | $770.14M |
Total Liabilities | $324.04M | $356.50M | $365.86M | $358.91M |
Cash & Equivalents | $157.65M | $163.63M | $108.32M | $80.98M |
Free Cash Flow OCF − CapEx | $8.36M | $37.06M | $38.78M | $25.37M |
Shares Outstanding | 104.68M | 106.65M | 107.76M | 109.78M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.